Form 4: NeuroMetrix Director Joshua Horowitz Reports Disposal of Shares Following Merger with electroCore

Sentiment:

SEC Form 4 Filing


Director Joshua Horowitz reports the disposal of NeuroMetrix shares due to the merger with electroCore, where shares were converted into cash and contingent value rights.

Summary

  • Joshua Horowitz, a director of NeuroMetrix, filed a Form 4 indicating changes in beneficial ownership.
  • The filing reports the disposal of NeuroMetrix common stock following the merger agreement with electroCore, Inc.
  • As of May 1, 2025, Horowitz disposed of 29,807 shares of common stock directly owned.
  • Additionally, 60,500 shares indirectly owned were disposed of.
  • The merger resulted in each share of NeuroMetrix common stock being converted into the right to receive cash and one contingent value right (CVR).
  • The cash consideration is a pro rata share of the company's net cash balance at the effective time of the merger, after certain deductions.
  • The CVR represents the right to receive contingent payments based on the terms of a contingent value rights agreement.
  • Palm Management (US) LLC, as the investment manager of Palm Global Small Cap Master Fund LP, may be deemed a beneficial owner of the indirectly held shares.
  • Horowitz disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: Neutral sentiment as it primarily reports a transaction related to a previously announced merger. The impact is factual and doesn't inherently suggest positive or negative outcomes.

Future Outlook

The document outlines the immediate financial impact of the merger, with future payments potentially tied to the contingent value rights agreement.

Industry Context

Mergers and acquisitions are common in the medical technology sector, often driven by the desire to consolidate resources, expand market reach, or acquire new technologies. This merger reflects a strategic move within the industry.

Stakeholder Impact

  • Shareholders received cash and CVRs, impacting their investment value.
  • Employees may experience changes due to the merger, such as restructuring or new management.

Key Dates

DateDescription
12/17/2024Date of the Agreement and Plan of Merger between NeuroMetrix, electroCore, and Nexus Merger Sub Inc.
05/01/2025Date of the transaction (disposal of shares) reported by Joshua Horowitz.
05/05/2025Date of signature for the Form 4 filing.

Keywords

Form 4, NeuroMetrix, electroCore, Merger, Beneficial Ownership, Joshua Horowitz, Shares, Contingent Value Rights, Cash Consideration

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.